Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.21+0.20 (+9.95%)
Close on Nov 13, 2026Market cap $3.21MP/E –Yield –
Nexentis Technologies gross margin
Gross margin is gross profit as a percentage of revenue.
Nexentis Technologies's gross margin for the twelve months ending Sep 30, 2025 was 65.1%. For fiscal 2024 it was 21.4%, against 79.1% the year before. The highest annual figure on record is 81.3% in fiscal 2020.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 21.4% | −57.7 |
| FY2023 | Dec 31, 2023 | 79.1% | +19.3 |
| FY2022 | Dec 31, 2022 | 59.8% | −9.2 |
| FY2021 | Dec 31, 2021 | 69.0% | −12.3 |
| FY2020 | Dec 31, 2020 | 81.3% | +63.5 |
| FY2019 | Dec 31, 2019 | 17.8% | −56.2 |
| FY2018 | Dec 31, 2018 | 74.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | 0.0% | −64.7 |
| Q1 FY2025 | Mar 31, 2025 | 78.8% | +42.4 |
| Q4 FY2024 | Dec 31, 2024 | 61.0% | −53.5 |
| Q3 FY2024 | Sep 30, 2024 | -755.6% | −781.8 |
| Q2 FY2024 | Jun 30, 2024 | 64.7% | +0.0 |
| Q1 FY2024 | Mar 31, 2024 | 36.4% | −28.3 |
| Q4 FY2023 | Dec 31, 2023 | 114.5% | +62.1 |
| Q2 FY2023 | Jun 30, 2023 | 26.2% | −32.0 |
| Q1 FY2023 | Mar 31, 2023 | 64.7% | +12.4 |
| Q4 FY2022 | Dec 31, 2022 | 64.7% | +0.6 |
| Q3 FY2022 | Sep 30, 2022 | 52.4% | +27.5 |
| Q2 FY2022 | Jun 30, 2022 | 58.2% | −21.0 |
| Q1 FY2022 | Mar 31, 2022 | 52.2% | −45.4 |
| Q4 FY2021 | Dec 31, 2021 | 64.1% | −25.4 |
| Q3 FY2021 | Sep 30, 2021 | 24.8% | −42.5 |
| Q2 FY2021 | Jun 30, 2021 | 79.1% | +77.9 |
| Q1 FY2021 | Mar 31, 2021 | 97.6% | +23.9 |
| Q4 FY2020 | Dec 31, 2020 | 89.5% | – |
| Q1 FY2020 | Mar 31, 2020 | 67.3% | – |
| Q4 FY2019 | Dec 31, 2019 | 1.3% | – |
| Q1 FY2019 | Mar 31, 2019 | 73.8% | – |
See a number that looks wrong?